Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases (Q35090142)

6 August 2017

1 reference

title

Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases (English)

1 reference

6 August 2017

6

Gallo RC

1 reference

6 August 2017

Zagury D

1

1 reference

6 August 2017

Le Buanec H

2

1 reference

6 August 2017

Bizzini B

3

1 reference

6 August 2017

Burny A

4

1 reference

6 August 2017

Lewis G

5

1 reference

6 August 2017

1 April 2003

1 reference

Cytokine and Growth Factor Reviews

6 August 2017

1 reference

6 August 2017

14

1 reference

6 August 2017

2

1 reference

6 August 2017

123-137

1 reference

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Is immunotherapy for asthma worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Cytokine fields and the polarization of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Reciprocal control of T helper cell and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Antiproliferative action of interferon-α requires components of T-cell-receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Differentiation of T regulatory cells by immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

T regulatory cells 1 inhibit a Th2-specific response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Type I IFN modulates innate and specific antiviral immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Distinguishing characteristics of the interferon responses of primary and continuous mouse cell cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

QUANTITATIVE STUDIES ON VIRAL INTERFERENCE IN SUSPENDED L CELLS. IV. PRODUCTION AND ASSAY OF INTERFERON

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: Effect of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Inhibition of the dsRNA-dependent protein kinase by a peptide derived from the human immunodeficiency virus type 1 Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

1 reference

7 January 2021

Interferons in the persistence, pathogenesis, and treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

The relationship of serum alpha-interferon and ultrastructural markers in HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Viral interleukin-10 in chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Identification of the respiratory syncytial virus-induced immunosuppressive factor produced by human peripheral blood mononuclear cells in vitro as interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Interleukin-6 and prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

VEGF-mediated tumour angiogenesis: a new target for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Macrophages and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Classical and alloimmune anaphylactic degranulation of isolated single mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

IL-4: a key cytokine in atopy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

The TH1/TH2 paradigm in allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

An etiopathogenic role for the type I IFN system in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Development of anti-TNF therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Antibody humanization: a case of the 'Emperor's new clothes'?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Virus or a hapten-carrier complex can activate autoreactive B cells by providing linked T help.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

B-cell memory is short-lived in the absence of antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Fetal effects of epidermal growth factor deficiency induced in rats by autoantibodies against epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Therapeutic antibodies elicited by immunization against TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

AIDS vaccine therapy: phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Cuban vaccine tested in Canadian trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Tat toxoid as a component of a preventive vaccine in seronegative subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Continuous proliferation of murine antigen-specific helper T lymphocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Clinical trials of antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900004-2

7 January 2021

10.1016/S1359-6101(03)00004-2

Identifiers

DOI

1 reference

release_bgdrz5zjarfbzek4chknc3lfvu

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bgdrz5zjarfbzek4chknc3lfvu

24 November 2022

mapped directly with Wikidata item

1 reference